PURPOSE: We investigated whether repeat prostate biopsies are associated with more favorable prognoses, less extensive disease or higher rates of IC in patients who are ultimately diagnosed with prostate cancer and treated with RRP. MATERIALS AND METHODS: We examined standard clinical and pathological data on 1,357 patients treated with RRP from 1983 to 2001. In addition, we noted the rate of IC in a subgroup of 847 patients in whom tumor volume was measured. RESULTS: Cancer was found in 1,042 patients (77%) at the first biopsy, in 227 (17%) at the second biopsy, in 59 (4%) at the third biopsy and in 29 (2%) at the fourth or later biopsy. Patients with 2 or greater biopsies had a higher rate of clinical T1c stage cancer and larger prostates than patients with only 1 biopsy (each p < 0.0001). After RRP patients with 1 biopsy had a lower rate of organ confined tumors (61% vs 75%, p < 0.0001), and a higher rate of extracapsular extension, seminal vesicle invasion, lymph node metastases and Gleason sum 7 or greater than other patients. IC was found in 10% of patients with 1 biopsy and 18% of those with 2 or greater biopsies (p = 0.018). Despite these more favorable pathological outcomes there was no difference in biochemical recurrence rate. CONCLUSIONS: Although we found that a greater number of biopsies was related to a better pathological outcome after RRP, the number of biopsies did not predict disease recurrence. The increasing number of biopsies currently being performed, especially in patients with larger prostates, likely results in higher rates of IC.
PURPOSE: We investigated whether repeat prostate biopsies are associated with more favorable prognoses, less extensive disease or higher rates of IC in patients who are ultimately diagnosed with prostate cancer and treated with RRP. MATERIALS AND METHODS: We examined standard clinical and pathological data on 1,357 patients treated with RRP from 1983 to 2001. In addition, we noted the rate of IC in a subgroup of 847 patients in whom tumor volume was measured. RESULTS:Cancer was found in 1,042 patients (77%) at the first biopsy, in 227 (17%) at the second biopsy, in 59 (4%) at the third biopsy and in 29 (2%) at the fourth or later biopsy. Patients with 2 or greater biopsies had a higher rate of clinical T1c stage cancer and larger prostates than patients with only 1 biopsy (each p < 0.0001). After RRP patients with 1 biopsy had a lower rate of organ confined tumors (61% vs 75%, p < 0.0001), and a higher rate of extracapsular extension, seminal vesicle invasion, lymph node metastases and Gleason sum 7 or greater than other patients. IC was found in 10% of patients with 1 biopsy and 18% of those with 2 or greater biopsies (p = 0.018). Despite these more favorable pathological outcomes there was no difference in biochemical recurrence rate. CONCLUSIONS: Although we found that a greater number of biopsies was related to a better pathological outcome after RRP, the number of biopsies did not predict disease recurrence. The increasing number of biopsies currently being performed, especially in patients with larger prostates, likely results in higher rates of IC.
Authors: B Djavan; V Ravery; A Zlotta; P Dobronski; M Dobrovits; M Fakhari; C Seitz; M Susani; A Borkowski; L Boccon-Gibod; C C Schulman; M Marberger Journal: J Urol Date: 2001-11 Impact factor: 7.450
Authors: H B Carter; J D Pearson; E J Metter; L J Brant; D W Chan; R Andres; J L Fozard; P C Walsh Journal: JAMA Date: 1992 Apr 22-29 Impact factor: 56.272
Authors: Christopher B Anderson; Amy L Tin; Daniel D Sjoberg; John P Mulhall; Jaspreet Sandhu; Karim Touijer; Vincent P Laudone; James A Eastham; Peter T Scardino; Behfar Ehdaie Journal: BJU Int Date: 2015-07-20 Impact factor: 5.588
Authors: Ryan P Kopp; Sean P Stroup; Florian R Schroeck; Stephen J Freedland; Frederick Millard; Martha K Terris; William J Aronson; Joseph C Presti; Christopher L Amling; Christopher J Kane Journal: J Urol Date: 2012-04-11 Impact factor: 7.450
Authors: Neil Mendhiratta; Xiaosong Meng; Andrew B Rosenkrantz; James S Wysock; Michael Fenstermaker; Richard Huang; Fang-Ming Deng; Jonathan Melamed; Ming Zhou; William C Huang; Herbert Lepor; Samir S Taneja Journal: Urology Date: 2015-08-31 Impact factor: 2.649
Authors: Dong Jin Park; Ki Ho Kim; Tae Gwon Kwon; Chun Ii Kim; Cheol Hee Park; Jae Shin Park; Duck Youn Kim; Jae Soo Kim; Ki Hak Moon; Kyung Seop Lee Journal: Korean J Urol Date: 2014-11-10
Authors: Catalina Vasquez; Michael Kolinsky; Rume Djebah; Maxwell Uhlich; Bryan Donnelly; Adrian S Fairey; Eric Hyndman; Nawaid Usmani; Jackson Wu; Peter Venner; Dean Ruether; Gerald Todd; Michael Chetner; R Trafford Crump; Perrin H Beatty; John D Lewis Journal: BMJ Open Date: 2020-10-16 Impact factor: 2.692
Authors: Seung Je Lee; Insang Hwang; Eu Chang Hwang; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park Journal: Korean J Urol Date: 2013-06-12
Authors: Jennifer Creed; Laurence Klotz; Andrew Harbottle; Andrea Maggrah; Brian Reguly; Anne George; Vincent Gnanapragasm Journal: World J Urol Date: 2017-12-16 Impact factor: 4.226